Integer Holdings Co. (NYSE:ITGR) Short Interest Update

Integer Holdings Co. (NYSE:ITGR) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 2,230,000 shares, a growth of 5.7% from the November 30th total of 2,110,000 shares. Based on an average daily volume of 242,000 shares, the short-interest ratio is presently 9.2 days. Approximately 6.9% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Several research analysts have commented on ITGR shares. Benchmark lifted their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Truist Financial raised their price objective on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. KeyCorp increased their target price on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Wells Fargo & Company restated an “overweight” rating and issued a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Finally, Bank of America increased their price objective on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, Integer currently has an average rating of “Moderate Buy” and a consensus target price of $145.44.

Institutional Investors Weigh In On Integer

Several institutional investors have recently modified their holdings of the company. Contravisory Investment Management Inc. boosted its position in Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares in the last quarter. HighTower Advisors LLC boosted its position in shares of Integer by 0.8% in the 3rd quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock worth $1,579,000 after buying an additional 90 shares in the last quarter. Xponance Inc. grew its stake in Integer by 4.9% in the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider’s stock valued at $245,000 after acquiring an additional 99 shares during the last quarter. Azzad Asset Management Inc. ADV increased its holdings in Integer by 0.9% during the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock valued at $1,504,000 after acquiring an additional 107 shares in the last quarter. Finally, TD Private Client Wealth LLC raised its position in Integer by 15.5% during the third quarter. TD Private Client Wealth LLC now owns 1,420 shares of the medical equipment provider’s stock worth $185,000 after acquiring an additional 191 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Down 0.3 %

ITGR opened at $132.17 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. Integer has a 12 month low of $94.56 and a 12 month high of $142.76. The stock has a market capitalization of $4.43 billion, a P/E ratio of 40.79, a P/E/G ratio of 2.02 and a beta of 1.12. The business has a 50 day simple moving average of $135.18 and a 200-day simple moving average of $127.12.

Integer (NYSE:ITGR) last released its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The company had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.27 earnings per share. On average, equities analysts anticipate that Integer will post 5.33 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.